The Ufenau V German Asset Light fund, advised by Ufenau Capital Partners, has held its final closing at the fund’s hard cap of EUR227 million. In addition to commitments from returning investors, which included entrepreneurs that form part of Ufenau’s Industry Partner network, Ufenau V received new commitments from a
Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor Linden Capital Partners. Founded in 2001 and based in Overland Park, Kansas, ProPharma is a provider of outsourced medical information,
Livingstone has advised Info-Assure, a provider of cyber-security and information assurance services, on its sale to BSI. Headquartered in Farnborough, UK, Info-Assure provides information assurance, security testing and incident response services to clients in the government, defence, policing, banking, retail and energy sectors. It is one of only eleven companies
Seacoast Capital has held the closing of Seacoast Capital Partners IV with total commitments of USD239 million. Limited partners include banks, private pension funds, private foundations, insurance companies, family offices and high net worth individuals. Along with significant support from private limited partners, Seacoast received approval from the US
Abacus Group, a provider of hosted cloud IT solutions for alternative asset funds, has reported year-on-year growth of over 30 per cent up to the end of the third quarter of 2016. The company’s employee count also exceeded 100 as it expanded its footprint in the Boston, Los Angeles and
A company backed by private equity firm Permira is to acquire Tricor, a provider of integrated business, corporate and investor services in Asia Pacific, from The Bank of East Asia (BEA) and NWS. The total consideration amounts to HKD6,470 million (USD835 million), including at least HKD400 million (approximately USD50 million)
MTS Health Investors, a healthcare-focused private equity fund, has closed its fourth fund, MTS Health Investors IV, with USD365 million in limited partner and general partner commitments. The fund was oversubscribed and closed at its fundraising cap. Senior managing director Curtis S Lane says: “We are grateful for the
AREAM and Greentale Capital have established a joint venture that will leverage the combined experience of two teams in the renewable energy and investment management industries. The joint venture will assist institutional investors to gain high-quality exposure to investment opportunities in the renewable energy industry. Initially, the joint venture
Bowmark Capital, a mid-market private equity firm, is backing the buy-out of IT solutions provider Node4 Holdings from its previous institutional investor, LDC. Founded in Derby in 2004 by its then 23 year old chief executive Andrew Gilbert, Node4 is a provider of integrated IT solutions, hybrid infrastructure and cloud-enabled
IK Investment Partners’ IK Small Cap I Fund is to acquire APOSAN Dr Künzer, a pharmaceutical homecare company in Germany. Financial terms of the transaction have not been disclosed. APOSAN was founded in 1991 by Dr Clemens Künzer, with the purpose to service homecare patients through the compounding of
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
